The leaves of Bauhinia forficata L. (Fabaceae) are used in Brazilian folk medicine mainly as antidiabetic agent. They are rich in polyphenols, and kaempferitrin and other flavonoids are currently considered as basic chemical criteria for the quality and the effectiveness of extracts and phytopharmaceuticals derived from them. Aiming to expand the scope of current data of the chemical profile of B. forficata subsp. forficata, the present study employed HPLC-DAD and HPLC-DAD-ESI/MS to compare the flavonoid profile and kaempferitrin content in the leaves of specimens collected seasonally during one year, in two different locations in Southeastern Brazil: Rio de Janeiro (RJ) and São Paulo (SP) states. The data showed a variation in the flavonoid profile and in the kaempferitrin content depending on the place of collection and the season of the year. The target compound, kaempferitrin, was found to be only a minor constituent in RJ (0.21 -1.02 µg/mg), and was mostly absent or occurred as trace in SP location (0.00 -0.12 µg/mg). Some degree of similarity was observed in the flavonoid profiles according to the region of collection. In agreement with some published reports, the low and quite variable kaempferitrin content as well the wide variability of the flavonoid profiles brings into question the dubious matter of using these compounds as chemical markers for this medicinal species.
Introduction
Bauhinia forficata Link (Fabaceae) is a medium-sized tree found in Southeastern and Southern Brazil, popularly known as pata-de-vaca (cow's hoof) due to the bilobed shape of its leaves [1] . These leaves are used in the folk medicine in Brazil and other South American countries as helping in diabetes treatment insofar it presents a noteworthy anti-hyperglycemic action [2] [3] [4] [5] [6] . Currently, the Brazilian Health Ministry rolls this species among the priorities ones for scientific validation, toward developing a sugar-lowering phytopharmaceutical [7] .
A number of studies have demonstrated the antidiabetic property of aqueous, alcoholic and aqueous-alcoholic extracts from the leaves of Bauhinia species [5] [8]. In the line, the researchers have striven to correlate the hypoglycemic effect to the chemical content of Bauhinia species, in particular the flavonoid-enriched fraction [9] and the individual constituent kaempferitrin (kaempferol-3,7-O-α-dirhamnoside) ( Figure 1 ) [10] [11] .
Since it was firstly reported as a marked component in the methanolic extract of B. forficata leaves [12] , the flavonoid kaempferitrin has drawn the attention as a possible responsible for the antihyperglycemic activity. This hypothesis was later proven correct when a significant hypoglycemic effect was observed in normal rats as well as in alloxan-induced diabetic animals, by administering different doses of kaempferitrin isolated from the hydroethanolic leaf extract of B. forficata, followed by solvent partitioning and flash column chromatography [13] . Kaempferitrin was then employed to assess the quality of B. forficata Link by quantifying such a compound in diverse hydroalcoholic extracts, an approach that included comparing leaves collected in different locales [14] as well as commercial dried samples [15] . However, kaempferitrin was not detected in every sample of B. forficata leaves thereafter approached. For instance, a NMR-based investigation on the constituents of the leaf hydroalcoholic extract led to the characterization of other 7-O-rhamnopyranosyl derivatives of kaempferol and quercetin, including di-and tri-glycosides [16] . Furthermore, the LC/ESI-MS analysis of the leaf extract of B. forficata did not reveal the presence of kaempferitrin but instead characterized four other quercetin and kaempferol glycosides as constituents [17] . Ferreres et al. [18] by analyzing commercial and authentic samples of B. forficata towards α-glucosidase inhibitory activity suggested that the higher amounts of quercetin derivatives found in some samples could be responsible for their higher activities when compared to those samples rich in kaempferol derivatives.
On the other hand, Farag et al. [19] studying Egyptian Bauhinia spp. have observed by chemometric approaches no correlation between total flavonoid content and α-glucosidase inhibition for B. forficata, which was speculated be related to the major content of flavonoid glycosides instead of free flavonoids.
Furthermore, other kaempferol and quercetin glycosides were reported to be involved on the glucose-6-phosphatase inhibition effect of B. megalandra leaves [20] while a megastigmane glycoside from B. variegata was shown to increase insulin secretion [21] . Moreover, other compound present in the B. forficata leaf extract, as trigonelin, quercetin, rutin and other flavonol glycosides [22] [23] , are endowed with antidiabetic activity [24] .
There is nowadays a growing concern onto considering a polyphenols/flavonoid more unfolded profile to authenticate and control the quality of B. forficata samples 
Materials and Methods

Chemicals
Analytical grade methanol (MeOH), formic acid (HCOOH) and HPLC grade acetonitrile (CH 3 CN) were purchased from Tedia-Brazil. Milli-Q grade water was used for HPLC and UPLC. The kaempferitrin used as reference compound was previously isolated from the leaves of Uncaria guianensis (99% purity) [30] .
Plant Material
Leaves of Bauhinia forficata were collected from different trees in two different 
Preparation of the Extracts
The extracts were prepared using a modified procedure previously developed to assess the kaempferitrin content from the leaves of Uncaria guianensis [23] . After drying at room temperature, grinding in a stainless-steel blender and then sieving to particle size ≤ 0.177 mm, 250 mg of B. forficata leaves were extracted with 9.5 mL of MeOH with ultrasound assistance for 18 min. The mixture was centrifuged, the supernatant was separated, and the process repeated five times.
The supernatants were pooled, and the solvent was evaporated under low pressure. Extract yields were determinate on dried weight.
HPLC-DAD Analyses
The HPLC analyses were performed using Shimadzu (VP) equipment with two 
HPLC-MS Analyses
High 
Results and Discussion
In our study, evaluation of the flavonoid profile and kaempferitrin content in B. Table 2 for peak characterization. * ≡ kaempferitrin signal.
The presence of kaempferitrin in the extracts was indicated by matching its retention time (R t = 30.2 min) and identity of the UV-spectrum with the reference compound, moreover than being thereafter confirmed by the fortification procedures. The kaempferitrin content in B. forficata leaf extracts varied from 0.21 to 1.04 μg/mg for RJ specimens, and was mostly absent or occurred as trace compounds in the SP samples. Most of these latter collections resulted extracts containing amounts of kaempferitrin below the quantitation limit (0.09 μg/mg).
In these cases, the contents of kaempferitrin could be inferred from the calibration curve; however, such an extrapolation was eventually considered worthless (Table 1) .
Overall, our data corroborates some previously reports on the chemical variability of the flavonoid profile in B. forficata leaves [14] [19] [25] . The extracts approached in this study showed the predominance of glycosylated flavonols, which were primarily characterized by their R t (based on the R t of kaempferitrin used as reference) and by their UV spectra as derivatives of kaempferol (λ MAX~2 65 nm), quercetin or isorhamnetin or myricetin (λ MAX~2 55 nm) [31] ( Figure 2 ). All these compounds have been previously described in the leaves of (Table 2 ). In most of the cases, the UV-suggested aglycones were corroborated by the occurrence of their respective fragment in the mass spectrum. These results align well with those obtained from the detailed analysis performed by Ferreres et al. when approaching the leaves of B. forficata from Southern Brazilian, using a variation of the same technique employed here [18] .
Some researchers have also caught the attention to the unavailability of reports on antidiabetic activity of other kaempferol glycosides that are usually present in the B. forficata extracts [16] [26] [33] . Thereby, the emerging question concerns to achieve a steady and reproducible chromatographic profile, based on either an individual compound or a group of phenolics, aiming at establishing a fingerprint to refer the quality of the raw material, herbal drug or phytopharmaceutical derived from this important medicinal species. As being a current issue in this standardizing context, the virtual absence of kaempferitrin in the extracts has to be carefully considered. In spite of the some advances in the quality control of the raw material, developing medicinal products from this species requires extending studies in order to achieve the optimum correlation between efficacy and chemical profile for B. forficata extracts. Additionally, it is well known that environmental factors such as seasonality, circadian rhythm, radiation, temperature, altitude and humidity can modify the secondary metabolism thus interfering quantitatively and qualitatively in the production of Figure 2 . Peaks 1 and 2 afforded identical UV spectra, but were not separated in the HPLC-MS experiment. 2 Trace level in most of the SP samples (see text). K = kaempferol, Q = quercetin, I = isorhamnetin. 3 LC-ESI-MS in negative mode applied to samples RJ-MAR2011 and SP-T3-AUG2009 (see experimental and Table 1 ). Excepting peak 7 (20%), all others showed [M-H]-ion as the base peak. 4 Based on the UV typical profiles [31] and comparing MS data with those reported in [18] and [27] ; K = kaempferol; Q = quercetin, I = isorhamnetin. Most spectra showed fragments corresponding to K (m/z 283) or Q (m/z 301) aglycones.
compounds by the plant [34] . Also stressing conditions from oxidative or hydric unbalance, for instance, can modify the plants biosynthetic pathway and induce them to produce chemical defenses in response to changes in the habitat [35] [36]. All these nuances have to be duly considered when aiming standardization of medicinal extracts [37] . of glycosylated aglycones present in each one. This feature was also suggested by the authors as implying of distinct levels of biological responses [18] . The present study is the first to approach the polyphenol profile of B. forficata subsp. forficata botanically certified.
Concluding Remarks
The data presented in this study show the complex question of considering the phenolic content of Bauhinia forficata leaves-be it the flavonoid profile or another phenolic group profile, or even an individual compound-as a tool to the quality control of the vegetal raw material, herbal and phytopharmaceutical derived from this species. Additionally, the spontaneous growth of two B. forficata subspecies regarded as anti-hyperglycemic also demonstrates the need for a precise botanical classification when approaching medicinal properties of this species. Further studies on the correlation between the chemical composition and therapeutic property of this important antidiabetic species are necessary.
